In this randomized clinical trial, a 5-day course of oral ivermectin administered during the first week of #COVID19 illness did not reduce the risk of developing severe disease, when compared with standard of care alone. ja.ma/3H1BGpO

5:00 PM ยท Feb 18, 2022

4
5
2
13